By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Concealed RepublicanConcealed Republican
  • Home
  • Latest News
  • Guns
  • Politics
  • Videos
Reading: HHS SEC ROBERT F KENNEDY JR: Trump’s executive order aims to slash American drug prices to match global rates
Share
Notification Show More
Font ResizerAa
Font ResizerAa
Concealed RepublicanConcealed Republican
  • News
  • Guns
  • Politics
  • Videos
  • Home
  • Latest News
  • Guns
  • Politics
  • Videos
Have an existing account? Sign In
Follow US
  • Advertise
  • Advertise
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Concealed Republican > Blog > News > HHS SEC ROBERT F KENNEDY JR: Trump’s executive order aims to slash American drug prices to match global rates
News

HHS SEC ROBERT F KENNEDY JR: Trump’s executive order aims to slash American drug prices to match global rates

Jim Taft
Last updated: May 17, 2025 11:44 am
By Jim Taft 4 Min Read
Share
HHS SEC ROBERT F KENNEDY JR: Trump’s executive order aims to slash American drug prices to match global rates
SHARE

Join Fox News for access to this content

Plus special access to select articles and other premium content with your account – free of charge.

By entering your email and pushing continue, you are agreeing to Fox News’ Terms of Use and Privacy Policy, which includes our Notice of Financial Incentive.

Please enter a valid email address.

Having trouble? Click here.

NEWYou can now listen to Fox News articles!

President Donald Trump’s bold executive order on drug pricing isn’t just policy—it’s a revolution in healthcare affordability. The plan is simple yet transformative: ensure Americans pay no more for medications than citizens of other wealthy nations.

Consider this stark reality: a GLP-1 drug costing $88 in London commands $1,000 in the United States. Even after manufacturer discounts to insurers, Americans still pay over $400—for the identical medication, from the same company, produced in the same facility. This disparity is especially galling when pharmaceutical companies extract 70% of their profits from America—a nation representing just 4% of the world’s population. This global free-riding on American patients ends now.

Industry leaders recognize this imbalance. I’ve already engaged with CEOs from four major American pharmaceutical companies and a foreign manufacturer eager to relocate to the U.S. Their response has been encouraging, but we’re prepared to act decisively if necessary. U.S. Health and Human Services and Centers for Medicare & Medicaid Services (CMS) possess the statutory authority to deliver on President Trump’s commitment: other developed nations must pay more, so Americans can pay less, thus preserving the innovation pipeline.

PRESIDENT TRUMP TAKES ON ‘BIG PHARMA’ BY SIGNING EXECUTIVE ORDER TO LOWER DRUG PRICES

Americans deserve both groundbreaking therapies and affordable access to them. Yet according to the Kaiser Family Foundation, nearly one-third of patients skip prescribed medications due to cost—an unacceptable reality in the world’s wealthiest nation.

While prevention through healthier lifestyles remains our best strategy for reducing medication dependence, certain treatments will always be essential. The pharmaceutical industry has delivered remarkable advancements in cancer and autoimmune therapies that benefit patients worldwide. 

CLICK HERE FOR MORE FOX NEWS OPINION

We value continued innovation as a core American principle, but we cannot indefinitely subsidize global medical progress while other wealthy nations contribute disproportionately little.

President Trump’s negotiation approach has already proven effective with NATO, where European countries responded to accountability by making historic reinvestments that strengthened the alliance. The same principle applies here. The President and I stand united: global free riding on American patients must end.

CMS, with Dr. Mehmet Oz at the helm, extends beyond payment reform to fundamentally realigning care delivery incentives. This initiative will protect safety nets for vulnerable populations while addressing the financial pressures facing state partners and federal programs—particularly Medicaid, which has seen dramatic growth in both enrollment and costs.

The coming months will be decisive in achieving President Trump’s prescription for a healthier America—one where innovation thrives, and patients no longer shoulder an unfair share of the global healthcare burden.

CLICK HERE TO READ MORE FROM ROBERT F. KENNEDY JR.

Read the full article here

You Might Also Like

Belize Ahead of the Curve on Guns in One Key Way

Tufts University student arrest: Top Dems want answers from Noem, Rubio, ICE

Florida Sheriff: ‘You Should Expect to be Shot’

Boise, Salt Lake City adopt the pride flag as official symbols

Tom Brady could be coming out of retirement, and Trump may be the reason: Report

Share This Article
Facebook X Email Print
Previous Article Shawn Ryan's Everyday Carry: 2024 Edition Shawn Ryan's Everyday Carry: 2024 Edition
Next Article The Republicans who could derail reconciliation The Republicans who could derail reconciliation
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

- Advertisement -
Ad image

Latest News

Armed DoorDash Driver Returns Drunk, Demands Tip, Grandpa Turns Tables with Firearm [WATCH]
Armed DoorDash Driver Returns Drunk, Demands Tip, Grandpa Turns Tables with Firearm [WATCH]
Politics
Trump, Musk feud explodes over ‘big, beautiful bill’ clash
Trump, Musk feud explodes over ‘big, beautiful bill’ clash
News
Here’s what happened this week during Trump’s 20th week in office
Here’s what happened this week during Trump’s 20th week in office
News
Dems Favorite MS-13 Gang Banger Indicted Over Years Long Human Trafficking Operation [WATCH]
Dems Favorite MS-13 Gang Banger Indicted Over Years Long Human Trafficking Operation [WATCH]
Politics
The Human Rights Campaign
The Human Rights Campaign
Politics
Vox Misses the Plot Entirely on SCOTUS Decision In Smith & Wesson v. Mexico
Vox Misses the Plot Entirely on SCOTUS Decision In Smith & Wesson v. Mexico
News
© 2025 Concealed Republican. All Rights Reserved.
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?